MedTrace Logo

Sevoflurane in Electroconvulsive Therapy

NCT01905904 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-05-16

No results posted yet for this study

Summary

The purpose of the study was to investigate the effects of different doses of sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles

Conditions

  • ECT
  • Anesthesia

Interventions

DRUG

sevorane

Sevorane 4% Sevorane 7%

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Huseyin Toprak, Professor · Inonu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-05-31
Completion
2013-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01905904 on ClinicalTrials.gov